Our study revealed that HP-β-CD, a potential therapy for NPC [34,35], failed to ameliorate cerebellar degeneration in Snx14-deficient mice, which suggests that SNX14 deletion may lead to Purkinje cell degeneration through a cholesterol-independent mechanism. Here, SNX14 is linked to nasopharyngeal carcinoma.